Therapeutic Effects of Dietary Soybean Genistein on Triple-Negative Breast Cancer via Regulation of Epigenetic Mechanisms

Consumption of dietary natural components such as genistein (GE) found in soy-rich sources is strongly associated with a lower risk of breast cancer. However, bioactive dietary component-based therapeutic strategies are largely understudied in breast cancer treatment. Our investigation sought to elu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Manvi Sharma, Itika Arora, Min Chen, Huixin Wu, Michael R. Crowley, Trygve O. Tollefsbol, Yuanyuan Li
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/56c87986f1564d0da6f64f3fa99de391
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:56c87986f1564d0da6f64f3fa99de391
record_format dspace
spelling oai:doaj.org-article:56c87986f1564d0da6f64f3fa99de3912021-11-25T18:35:29ZTherapeutic Effects of Dietary Soybean Genistein on Triple-Negative Breast Cancer via Regulation of Epigenetic Mechanisms10.3390/nu131139442072-6643https://doaj.org/article/56c87986f1564d0da6f64f3fa99de3912021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6643/13/11/3944https://doaj.org/toc/2072-6643Consumption of dietary natural components such as genistein (GE) found in soy-rich sources is strongly associated with a lower risk of breast cancer. However, bioactive dietary component-based therapeutic strategies are largely understudied in breast cancer treatment. Our investigation sought to elucidate the potential mechanisms linking bioactive dietary GE to its breast cancer chemotherapeutic potential in a special subtype of aggressive breast cancer—triple-negative breast cancer (TNBC)—by utilizing two preclinical patient-derived xenograft (PDX) orthotopic mouse models: BCM-3204 and TM00091. Our study revealed that administration of GE resulted in a delay of tumor growth in both PDX models. With transcriptomics analyses in TNBC tumors isolated from BCM-3204 PDXs, we found that dietary soybean GE significantly influenced multiple tumor-regulated gene expressions. Further validation assessment of six candidate differentially expressed genes (DEGs)—<i>Cd74</i>, <i>Lpl</i>, <i>Ifi44</i>, <i>Fzd9</i>, <i>Sat1</i> and <i>Wwc1</i>—demonstrated a similar trend at gene transcriptional and protein levels as observed in RNA-sequencing results. Mechanistically, GE treatment-induced <i>Cd74</i> downregulation regulated the NF-κB/Bcl-xL/TAp63 signal pathway, which may contribute to soybean GE-mediated therapeutic effects on TNBC tumors. Additionally, our findings revealed that GE can modify expression levels of key epigenetic-associated genes such as DNA methyltransferases (<i>Dnmt3b</i>), ten-eleven translocation (<i>Tet3</i>) methylcytosine dioxygenases and histone deacetyltransferase (<i>Hdac2</i>), and their enzymatic activities as well as genomic DNA methylation and histone methylation (H3K9) levels. Collectively, our investigation shows high significance for potential development of a novel therapeutic approach by using bioactive soybean GE for TNBC patients who have few treatment options.Manvi SharmaItika AroraMin ChenHuixin WuMichael R. CrowleyTrygve O. TollefsbolYuanyuan LiMDPI AGarticlegenisteintriple-negative breast cancer (TNBC)patient-derived xenograft (PDX)epigeneticRNA-seqcancer therapyNutrition. Foods and food supplyTX341-641ENNutrients, Vol 13, Iss 3944, p 3944 (2021)
institution DOAJ
collection DOAJ
language EN
topic genistein
triple-negative breast cancer (TNBC)
patient-derived xenograft (PDX)
epigenetic
RNA-seq
cancer therapy
Nutrition. Foods and food supply
TX341-641
spellingShingle genistein
triple-negative breast cancer (TNBC)
patient-derived xenograft (PDX)
epigenetic
RNA-seq
cancer therapy
Nutrition. Foods and food supply
TX341-641
Manvi Sharma
Itika Arora
Min Chen
Huixin Wu
Michael R. Crowley
Trygve O. Tollefsbol
Yuanyuan Li
Therapeutic Effects of Dietary Soybean Genistein on Triple-Negative Breast Cancer via Regulation of Epigenetic Mechanisms
description Consumption of dietary natural components such as genistein (GE) found in soy-rich sources is strongly associated with a lower risk of breast cancer. However, bioactive dietary component-based therapeutic strategies are largely understudied in breast cancer treatment. Our investigation sought to elucidate the potential mechanisms linking bioactive dietary GE to its breast cancer chemotherapeutic potential in a special subtype of aggressive breast cancer—triple-negative breast cancer (TNBC)—by utilizing two preclinical patient-derived xenograft (PDX) orthotopic mouse models: BCM-3204 and TM00091. Our study revealed that administration of GE resulted in a delay of tumor growth in both PDX models. With transcriptomics analyses in TNBC tumors isolated from BCM-3204 PDXs, we found that dietary soybean GE significantly influenced multiple tumor-regulated gene expressions. Further validation assessment of six candidate differentially expressed genes (DEGs)—<i>Cd74</i>, <i>Lpl</i>, <i>Ifi44</i>, <i>Fzd9</i>, <i>Sat1</i> and <i>Wwc1</i>—demonstrated a similar trend at gene transcriptional and protein levels as observed in RNA-sequencing results. Mechanistically, GE treatment-induced <i>Cd74</i> downregulation regulated the NF-κB/Bcl-xL/TAp63 signal pathway, which may contribute to soybean GE-mediated therapeutic effects on TNBC tumors. Additionally, our findings revealed that GE can modify expression levels of key epigenetic-associated genes such as DNA methyltransferases (<i>Dnmt3b</i>), ten-eleven translocation (<i>Tet3</i>) methylcytosine dioxygenases and histone deacetyltransferase (<i>Hdac2</i>), and their enzymatic activities as well as genomic DNA methylation and histone methylation (H3K9) levels. Collectively, our investigation shows high significance for potential development of a novel therapeutic approach by using bioactive soybean GE for TNBC patients who have few treatment options.
format article
author Manvi Sharma
Itika Arora
Min Chen
Huixin Wu
Michael R. Crowley
Trygve O. Tollefsbol
Yuanyuan Li
author_facet Manvi Sharma
Itika Arora
Min Chen
Huixin Wu
Michael R. Crowley
Trygve O. Tollefsbol
Yuanyuan Li
author_sort Manvi Sharma
title Therapeutic Effects of Dietary Soybean Genistein on Triple-Negative Breast Cancer via Regulation of Epigenetic Mechanisms
title_short Therapeutic Effects of Dietary Soybean Genistein on Triple-Negative Breast Cancer via Regulation of Epigenetic Mechanisms
title_full Therapeutic Effects of Dietary Soybean Genistein on Triple-Negative Breast Cancer via Regulation of Epigenetic Mechanisms
title_fullStr Therapeutic Effects of Dietary Soybean Genistein on Triple-Negative Breast Cancer via Regulation of Epigenetic Mechanisms
title_full_unstemmed Therapeutic Effects of Dietary Soybean Genistein on Triple-Negative Breast Cancer via Regulation of Epigenetic Mechanisms
title_sort therapeutic effects of dietary soybean genistein on triple-negative breast cancer via regulation of epigenetic mechanisms
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/56c87986f1564d0da6f64f3fa99de391
work_keys_str_mv AT manvisharma therapeuticeffectsofdietarysoybeangenisteinontriplenegativebreastcancerviaregulationofepigeneticmechanisms
AT itikaarora therapeuticeffectsofdietarysoybeangenisteinontriplenegativebreastcancerviaregulationofepigeneticmechanisms
AT minchen therapeuticeffectsofdietarysoybeangenisteinontriplenegativebreastcancerviaregulationofepigeneticmechanisms
AT huixinwu therapeuticeffectsofdietarysoybeangenisteinontriplenegativebreastcancerviaregulationofepigeneticmechanisms
AT michaelrcrowley therapeuticeffectsofdietarysoybeangenisteinontriplenegativebreastcancerviaregulationofepigeneticmechanisms
AT trygveotollefsbol therapeuticeffectsofdietarysoybeangenisteinontriplenegativebreastcancerviaregulationofepigeneticmechanisms
AT yuanyuanli therapeuticeffectsofdietarysoybeangenisteinontriplenegativebreastcancerviaregulationofepigeneticmechanisms
_version_ 1718410954267426816